KOSPI · Healthcare · ₩121B
₩5,120-0.97%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 1.7% · as of 26.10.27
Among 34 바이오 peers
Quarterly Revenue Growth
“외형 성장은 이어지지만 이익으로 이어지는지는 더 봐야 해요.”
In the company's words · 2026 2분기 filing